Report updated May 20, 2026
UpToDate Lexidrug
For healthcare professionals including pharmacists, physicians, nurses, and students requiring evidence-based drug information.
UpToDate Lexidrug is a challenged medical app that is available. With a 4.2/5 rating from 7.6K reviews, it faces significant user friction. Users particularly appreciate reliable clinical reference content remains a daily essential for medical professionals in clinical settings, though persistent database download failures prevent access to critical drug interactions and compatibility information remains a common concern.
What is UpToDate Lexidrug?
UpToDate Lexidrug is a professional-grade drug reference app providing clinical monographs, interaction checkers, and medical calculators for healthcare providers.
Clinicians hire this tool for evidence-based, offline-accessible drug information that ensures patient safety during point-of-care decisions.
Current Momentum
v9.4 · 1w ago
Maintenance- Ships general bug fixes only.
- Last major release Apr 2026.
Active Nemesis
Drugs.com Medication Guide
By Drugs.com
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Interactive tool to identify potential adverse reactions between multiple medications
Ability to store drug monographs and clinical content locally on the device
Integrated suite of hundreds of clinical calculators for dosing and therapeutic support
Clinical information reviewed and updated daily by an internal editorial team
How much does it cost?
- 14-day free trial
- $29.99/month
Subscription model anchored at $29.99/month, targeting professional users with a 14-day trial conversion funnel.
Who Built It?
Providing healthcare professionals with evidence-based drug information and clinical decision support tools at the point of care.
Portfolio
1
Apps
Explore the full Lexi-Comp report
Portfolio breakdown, audience, momentum, and every app published by Lexi-Comp.
What do users think recently?
High confidence · Latest 66 of 106 total reviews analyzed · Based on 106 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a frustrated sentiment. Users appreciate reliable clinical reference content remains a daily essential for medical professionals in clinical settings, but report persistent database download failures prevent access to critical drug interactions and compatibility information and ui navigation changes hide essential drug library tools behind excessive menu clicks post-update.
What Users Love
What Frustrates Users
What Users Want
How have ratings & review volume moved?
Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.
Vertical markers = app releases. Hover any release for the post-release impact delta.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for UpToDate Lexidrug?
Where is it available?
Localized markets (9)
How's The Medical Market?
**Pricing**: Subscription model at $29.99/month, anchored by a 14-day free trial funnel. **Performance**: The app maintains a consistent presence in the Medical category, with #17 Grossing in the US and #33 Grossing across multiple international markets, though free-tier chart rankings fluctuate significantly (e.g., #81 to #189 in various regions).
How does it evolve in the Medical market?
UpToDate Lexidrug holds a #17 Grossing position in the US Medical category, reflecting strong professional monetisation despite a high-friction UI. The gap between its high-value clinical content and the recent technical instability creates a vulnerability to niche competitors.
Rank progression
168 active rankings tracked — 30-day window
Which niche is UpToDate Lexidrug in?
to support safe and effective medication decisions
Explore the full Pharmacology Guides niche
Every app in this space — 6 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
With over 36,000 reviews and a high-velocity release cadence, this app dominates the general-purpose drug reference market.
Differentiators
- Offers a massive, free-to-access consumer-facing database that captures broader search intent than professional-only tools.
- Maintains a high release frequency of 6 updates in six months, ensuring rapid adaptation to platform changes.
- Provides a comprehensive pill identification tool integrated directly into the core medication guide experience.
Head to head
The target app must emphasize its clinical depth and professional-grade decision support to differentiate from the broader, high-volume reach of Drugs.com.
Contenders(2)
A trusted, authoritative brand that provides high-quality clinical content for medical professionals.
Differentiators
- Leverages the prestigious Merck Manual brand to establish immediate clinical authority and trust with medical professionals.
- Provides comprehensive, peer-reviewed medical content that serves as a primary reference for complex clinical decision-making.
Highly specialized niche leader with strong professional loyalty and consistent update velocity.
Differentiators
- Focuses exclusively on antimicrobial therapy, creating a deep, specialized workflow that general apps cannot replicate.
- Maintains a high update frequency of 7 releases in six months, reflecting a commitment to current clinical guidelines.
Same space(4)
A legacy professional drug reference tool that competes directly for the clinical audience.
Differentiators
- Provides deep, institutional-grade drug information that is often integrated into hospital-wide clinical systems.
- Focuses on high-stakes clinical safety data, catering to the specific needs of pharmacists and hospital clinicians.
A social-professional network that provides clinical context through shared medical cases.
Differentiators
- Facilitates peer-to-peer learning through a visual, case-based social network for healthcare professionals.
- Drives high engagement through community-driven discussions on rare and complex clinical presentations.
Adjacent toolset focusing on clinical calculators rather than drug monographs.
Differentiators
- Provides a vast library of clinical calculators that streamline complex medical scoring and risk assessment workflows.
- Offers a highly interactive user experience that complements static drug reference apps like the target.
A direct competitor in the clinical decision support space, focusing on evidence-based medicine.
Differentiators
- Integrates evidence-based clinical summaries designed specifically for rapid point-of-care decision support in hospital settings.
- Utilizes a robust editorial process that prioritizes the most current clinical evidence over general drug information.
New entrants(1)
A focused, single-utility app that addresses a specific, high-frequency user pain point.
Differentiators
- Reduces user friction by isolating the pill identification workflow into a dedicated, lightweight application.
- Capitalizes on the parent brand's extensive database to provide rapid, accurate visual identification of medications.
Compare UpToDate Lexidrug against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for UpToDate Lexidrug
Strengths to defend, gaps to attack
Core Strengths
- Daily editorial updates establish clinical authority
- Offline database access creates high switching costs
Critical Frictions
- Persistent database download failures
- UI navigation regressions hiding core tools
- Authentication loops locking out paid subscribers
Growth Levers
- Expand B2B institutional partnerships
- Integrate calculators into monograph view
Market Threats
- Drugs.com high-velocity release cadence
- Professional migration to stable niche tools
What are the next best moves?
Rebuild database download logic because download failures are the #1 complaint → restore core clinical utility
Database download failures are the top-cited complaint, directly preventing access to life-critical drug interaction data.
Trade-off: Pause the medical calculator UI refresh — stability is the primary churn driver.
Restore drug library icon to home screen because UI navigation complaints are the #2 churn risk → improve daily workflow
User feedback explicitly requests returning the drug database icon to the main landing page to reduce menu clicks.
Trade-off: Deprioritize the new onboarding tutorial — current users are the priority for retention.
A counter-intuitive read
The app's biggest risk is not a competitor feature, but its own maintenance-mode UI, which is currently more effective at driving users to Drugs.com than any marketing campaign could.
Feature Gaps vs Competitors
- Real-time pill identification (available in Drugs.com but missing here)
- Social case-based learning (available in Figure 1 but missing here)
Key Takeaways
UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base.
Where Is It Heading?
Declining
The professional medical reference market is consolidating around tools that provide high-speed, reliable point-of-care access. UpToDate Lexidrug's current technical instability and UI friction leave it exposed to niche competitors, so the team must shift from feature-parity to stability-first engineering to prevent further subscription loss.
Persistent database download failures prevent access to critical clinical data, which directly causes professional churn to more stable competitors.
UI navigation changes hide essential tools behind excessive menus, slowing down point-of-care workflows and reducing daily active usage.